News Releases

November 20, 2023   NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference

November 15, 2023   NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML

November 2, 2023   NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results

October 17, 2023   Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)

September 26, 2023   NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease

September 12, 2023   A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC

September 7, 2023   NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen

September 5, 2023   Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease

August 31, 2023   NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference

August 3, 2023   NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results